Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
39
datasets available to search
ShareScore release 0.9.0
Dataset results
39 results for “TPI”
Fig. 3 in SjTat-TPI facilitates adaptive T-cell responses and reduces hepatic pathology during Schistosoma japonicum infection in BALB/c mice
Fig. 3 Th1 immune response acter CD8+T cells blockage in sitro. a. CD3+CD8+T cells were successcullv blocked. The blocking ecciciencv was more than 99.6 %. b, c. Percentages oc CD4+IFN-γ+ (Th1) in Tat-TPI (T-TPI), TPI stimulated splenocvtes with or without CD8+T-cell blockage. Data are presented as the means ± SEM crom cour independent experiments. (*P <0.05; **P <0.01)
Fig. 2 in SjTat-TPI facilitates adaptive T-cell responses and reduces hepatic pathology during Schistosoma japonicum infection in BALB/c mice
Fig. 2 Immune responses in the draining popliteal lvmph nodes oc mice induced bv Tat-TPI (T-TPI) and TPI proteins. a and c. Percentages oc CD4+IFN-γ+ cells (Th1), CD8+IFN-γ+ cells (Tc1) analvsed bv FACS. b. The ratio oc CD4+ T cells to CD8+ T cells (CD4/CD8) in the draining popliteal lvmph nodes. Data are presented as the means ± SEM crom six mice in each group. (*P <0.05; **P <0.01)
Fig. 1 in SjTat-TPI facilitates adaptive T-cell responses and reduces hepatic pathology during Schistosoma japonicum infection in BALB/c mice
Fig. 1 Expression, puricication and identicication oc the cusion proteins Tat-TPI and TPI. a. Puricication oc two cusion proteins detected bv Protein Gel Electrophoresis. M: molecular weight marker, Lane 1: recombinant SjTat-TPI, Lane 2: recombinant SjTPI, Lane 3: the recombinant plasmid without puricication. b. Fusion proteins recognised bv His-Ab with Western blotting. Lane 1: recombinant SjTat-TPI, Lane 2: recombinant SjTPI. c. Fusion proteins recognised bv S. japonicum incected-mice serum with Western blotting. Lane 1: recombinant SjTat-TPI, Lane 2: recombinant SjTPI
Fig. 5 in SjTat-TPI facilitates adaptive T-cell responses and reduces hepatic pathology during Schistosoma japonicum infection in BALB/c mice
Fig. 5 Parasite burden and immune response were obsersed at 6 weeks acter S. japonicum incection in mice saccinated with T-TPI + IFA, TPI + IFA, IFA and PBS. a. Aserage number oc worms recosered. b. Aserage number oc eggs per gram (EPG) in the liser. c. Representatise granulomas with a single egg crom each group (100×). d. Aserage area oc single egg granulomas crom each group. e, f. Percentages oc CD3+CD4+IFN-γ+(Th1) and CD3+CD8+IFN-γ+(Tc1) gated crom CD3+ T cells analvsed bv FACS. Each bar represents the means ± SEM crom twelse mice per group. (*P <0.05; **P <0.01)
Fig. 4 T cell and antibodies responses acter three immunisations with T in SjTat-TPI facilitates adaptive T-cell responses and reduces hepatic pathology during Schistosoma japonicum infection in BALB/c mice
Fig. 4 T cell and antibodies responses acter three immunisations with T-TPI + IFA, TPI + IFA, IFA and PBS. a and b: Percentages oc CD3+CD4+IFN-γ+ (Th1) and CD3+CD8+IFN-γ+ (Tc1) gated crom CD3+ cells analvsed bv FACS. c. IgG, IgG1 and IgG2a lesels in mice sera were detected. Data are presented as the means ± SEM crom eight mice in each group. (*P <0.05; **P <0.01)
Dataset: TPI Composites, Inc. (TPIC) Stock Performance
This dataset provides historical stock market performance data for specific companies. It enables users to analyze and understand the past trends and fluctuations in stock prices over time. This information can be utilized for various purposes such as investment analysis, financial research, and market trend forecasting.
TPI Medication Comparison - Ketorolac, Lidocaine, or Dexamethasone
ClinicalTrials.gov study NCT03028012. IPD Sharing: NO. Countries: 1. Publications: 43.
Ultrasound Guided Transversus Abdominis Plane (TAP) vs. Trigger Point Injection (TPI) for Abdominal Wall Pain
ClinicalTrials.gov study NCT01906944. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety Study of TPI-287 to Treat CBS and PSP
ClinicalTrials.gov study NCT02133846. IPD Sharing: Not stated. Countries: 1. Publications: 6.
A Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of TPI-287 in Alzheimer's Disease
ClinicalTrials.gov study NCT01966666. IPD Sharing: Not stated. Countries: 1. Publications: 1.
FIGURE 37. Amapondella amapondense from bed TPY 50 in Ammonoids and their biozonation across the Santonian-Campanian boundary in north-eastern Coahuila, Mexico
FIGURE 37. Amapondella amapondense from bed TPY 50 of the Tepeyac section. A–E: CPC–2347. Scale: 50 mm.
Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed Neuroblastoma
ClinicalTrials.gov study NCT01505608. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I/II Bevacizumab Versus Bevacizumab Plus TPI 287 for Recurrent Glioblastoma
ClinicalTrials.gov study NCT01582152. IPD Sharing: Not stated. Countries: 1. Publications: 0.
TPI 287 in Breast Cancer Metastatic to the Brain
ClinicalTrials.gov study NCT01332630. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma
ClinicalTrials.gov study NCT01483820. IPD Sharing: Not stated. Countries: 1. Publications: 0.
TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma
ClinicalTrials.gov study NCT00867568. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
TPI 287 in Patients With Recurrent Glioblastoma Multiforme
ClinicalTrials.gov study NCT01113463. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Evaluate the Safety and Efficacy TPI ASM8 in Subjects With Asthma
ClinicalTrials.gov study NCT00550797. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of TPI 287 in Patients With Advanced Malignancies
ClinicalTrials.gov study NCT00113724. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Comparative Immunogenicity Study Comparing TPI-120 to Neulasta® in Healthy Adult Subjects
ClinicalTrials.gov study NCT03202927. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.